• New $100M Program Aims to Improve Diversity in Clinical Trials
  • FDA Grants Fast Track Status, Rolling Review to Lumicell’s LUM Imaging System
  • FDA Approves Keytruda-chemo Combo for Advanced TNBC Positive for PD-L1
  • Breast Cancer Cell Sugars in Liquid Biopsies Could Be Key to Early Detection
  • Athenex Oncology Offers Free ‘Evidenced-based’ Lifestyle Guide for MBC Patients
  • Phase 3 Trial to Compare Enhertu to Kadcyla in HER2-Positive, High Risk Patients
  • FDA Approves FoundationOne Liquid CDx as Companion Diagnostic Test for Piqray Treatment
  • FDA Grants Fast Track to PC14586, Potential Therapy for Specific p53 Mutation
  • Adding Ibrance to Hormone Therapy Fails to Prolong Time Before Cancer Recurs, Trial Shows
  • COVID-19 Surgery Delays May Mean 2,700 More Breast Cancer Deaths Within 10 Years
  • Signatera Test for Residual Disease Will Be Used in New Phase 2 Breast Cancer Trial
  • Trodelvy Shows Superiority to Chemo for Advanced TNBC in Phase 3 Trial